Cas:114-33-0 N-METHYLNICOTINAMIDE manufacturer & supplier

We serve Chemical Name:N-METHYLNICOTINAMIDE CAS:114-33-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N-METHYLNICOTINAMIDE

Chemical Name:N-METHYLNICOTINAMIDE
CAS.NO:114-33-0
Synonyms:Nicotinic acid methylamide;N-Methylnicotinamide;N-methylnicotineamide;EINECS 204-046-4;MFCD00006384;N-methylpyridine-3-carboxamide;N-Methylnicotinsaeureamid;N-methyl nicotinamide;3-Pyridinecarboxamide,N-methyl;N-Methyl-3-pyridinecarboxamide;Nicotinamide,N-methyl;Nicotinyl Methylamide
Molecular Formula:C7H8N2O
Molecular Weight:136.15100
HS Code:2933399090

Physical and Chemical Properties:
Melting point:102-105 °C(lit.)
Boiling point:347.7ºC at 760 mmHg
Density:1.106 g/cm3
Index of Refraction:1.529
PSA:41.99000
Exact Mass:136.06400
LogP:0.83210

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Nicotinic acid methylamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Nicotinyl Methylamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-Methylnicotinsaeureamid Use and application,EINECS 204-046-4 technical grade,usp/ep/jp grade.


Related News: Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: ��Within the top 20 global companies that spent the most on R&D in 2018, the top spender �C despite having the second smallest annual revenue of the group at $15.28 billion �C is Celgene, whose R&D spend was equal to 37% of its annual revenue. N-METHYLNICOTINAMIDE manufacturer Schimpke, an assistant professor in the Division of Minimally Invasive and Bariatric Surgery at Rush Medical College in Chicago, and his colleagues point out that obesity is linked to a considerably higher risk for developing upwards of 40 different serious illnesses, including heart disease and diabetes. N-METHYLNICOTINAMIDE supplier Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: ��Within the top 20 global companies that spent the most on R&D in 2018, the top spender �C despite having the second smallest annual revenue of the group at $15.28 billion �C is Celgene, whose R&D spend was equal to 37% of its annual revenue. N-METHYLNICOTINAMIDE vendor With the continuous advancement of economic globalization, the division of labor and cooperation around the world has become increasingly apparent. The fine chemical industry has the foundation of global division of labor and cooperation due to its long and complex industrial chain. N-METHYLNICOTINAMIDE factory Factors that have a significant impact on the sales volume of APIs come from the production side, which mainly includes costs and processes.